These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30191766)

  • 1. Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.
    Abaji R; Ceppi F; Patel S; Gagné V; Xu CJ; Spinella JF; Colombini A; Parasole R; Buldini B; Basso G; Conter V; Cazzaniga G; Leclerc JM; Laverdière C; Sinnett D; Krajinovic M
    Pharmacogenomics; 2018 Oct; 19(15):1181-1193. PubMed ID: 30191766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
    Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
    Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
    Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cohort study of vincristine-induced peripheral neuropathy in children].
    Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
    Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
    Tunjungsari DA; Gunawan PI; Ugrasena IDG
    J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
    Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
    Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
    Ceppi F; Langlois-Pelletier C; Gagné V; Rousseau J; Ciolino C; De Lorenzo S; Kevin KM; Cijov D; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
    Pharmacogenomics; 2014 Jun; 15(8):1105-16. PubMed ID: 25084203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a single-nucleotide polymorphism within
    Aaron M; Nadeau G; Ouimet-Grennan E; Drouin S; Bertout L; Beaulieu P; St-Onge P; Shalmiev A; Veilleux LN; Rauch F; Petrykey K; Laverdière C; Sinnett D; Alos N; Krajinovic M
    Pharmacogenomics; 2019 Apr; 20(6):409-420. PubMed ID: 30983502
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
    Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
    Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
    Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.
    Stock W; Diouf B; Crews KR; Pei D; Cheng C; Laumann K; Mandrekar SJ; Luger S; Advani A; Stone RM; Larson RA; Evans WE
    Clin Pharmacol Ther; 2017 Mar; 101(3):391-395. PubMed ID: 27618250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study.
    Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
    Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
    Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.
    Petrykey K; Rezgui AM; Guern ML; Beaulieu P; St-Onge P; Drouin S; Bertout L; Wang F; Baedke JL; Yasui Y; Hudson MM; Raboisson MJ; Laverdière C; Sinnett D; Andelfinger GU; Krajinovic M
    Pharmacogenomics; 2021 Sep; 22(14):885-901. PubMed ID: 34505544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.